149 related articles for article (PubMed ID: 38640306)
21. A case report of malignant hyperthermia in a patient with myotonic dystrophy type I: A CARE-compliant article.
Yoo SW; Baek SJ; Kim DC; Doo AR
Medicine (Baltimore); 2021 Jun; 100(23):e25859. PubMed ID: 34114984
[TBL] [Abstract][Full Text] [Related]
22. Malignant hyperthermia.
Taiclet L
Anesth Prog; 1985; 32(4):140-2. PubMed ID: 3865561
[TBL] [Abstract][Full Text] [Related]
23. [Case of fulminant-malignant hyperthermia occurring on sixth sevoflurane anesthesia].
Sugiyama K; Toya A; Shimomatsu K; Saitoh Y; Manabe Y; Kohjitani A
Masui; 2011 Jun; 60(6):703-5. PubMed ID: 21710767
[TBL] [Abstract][Full Text] [Related]
24. Pathophysiology and Treatment of Malignant Hyperthermia.
Gregory H; Weant KA
Adv Emerg Nurs J; 2021 Apr-Jun 01; 43(2):102-110. PubMed ID: 33915557
[TBL] [Abstract][Full Text] [Related]
25. Malignant hyperthermia in the oral and maxillofacial surgery patient: an update.
Patil PM
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2011 Sep; 112(3):e1-7. PubMed ID: 21827956
[TBL] [Abstract][Full Text] [Related]
26. Malignant hyperthermia.
Rosenberg H; Davis M; James D; Pollock N; Stowell K
Orphanet J Rare Dis; 2007 Apr; 2():21. PubMed ID: 17456235
[TBL] [Abstract][Full Text] [Related]
27. Minor increase of endtidal CO2 during sevoflurane-induced malignant hyperthermia.
Bonciu M; de la Chapelle A; Delpech H; Depret T; Krivosic-Horber R; Aimé MR
Paediatr Anaesth; 2007 Feb; 17(2):180-2. PubMed ID: 17238892
[TBL] [Abstract][Full Text] [Related]
28. Anesthetic drugs and onset of malignant hyperthermia.
Visoiu M; Young MC; Wieland K; Brandom BW
Anesth Analg; 2014 Feb; 118(2):388-396. PubMed ID: 24445637
[TBL] [Abstract][Full Text] [Related]
29. [First report of malignant hyperthermia which occurred during laparoscopic surgery in Japan in a patient with typical family history].
Kobatake T; Kouchi A; Hashimoto M; Ono M; Saito N
Masui; 2006 Jan; 55(1):69-72. PubMed ID: 16440711
[TBL] [Abstract][Full Text] [Related]
30. [Propofol triggers a marked body temperature increase in a patient with fulminant malignant hyperthermia (MH) without inducing other symptoms of MH].
Murao K; Umegaki T; Masuzawa M; Inoue S; Nakao S; Shingu K
Masui; 2010 Jan; 59(1):92-6. PubMed ID: 20077777
[TBL] [Abstract][Full Text] [Related]
31. Malignant Hyperthermia-Susceptible Adult Patient and Ambulatory Surgery Center: Society for Ambulatory Anesthesia and Ambulatory Surgical Care Committee of the American Society of Anesthesiologists Position Statement.
Urman RD; Rajan N; Belani K; Gayer S; Joshi GP
Anesth Analg; 2019 Aug; 129(2):347-349. PubMed ID: 31166228
[TBL] [Abstract][Full Text] [Related]
32. Malignant hyperthermia with excellent response to small dose of dantrolene.
Chang KY; Ting CK; Chan KH; Tsai SK
Acta Anaesthesiol Taiwan; 2004 Dec; 42(4):241-5. PubMed ID: 15679136
[TBL] [Abstract][Full Text] [Related]
33. Malignant hyperthermia, a surgeon's nightmare.
Lowe MK
J Foot Surg; 1985; 24(2):139-41. PubMed ID: 2985684
[TBL] [Abstract][Full Text] [Related]
34. [Malignant hyperthermia in swine during isoflurane anesthesia].
Sümpelmann R; Bötel C; Zimmermann M; Krohn S; Strauss JM; Paul T
Dtsch Tierarztl Wochenschr; 1994 May; 101(5):207-8. PubMed ID: 8013300
[TBL] [Abstract][Full Text] [Related]
35. Malignant Hyperthermia during Thoracoscopic Pulmorrhaphy in a 70-Year-Old Man.
Sakai M; Murakami N; Kitamura Y; Sato S; Iwama H; Nomura A
Case Rep Anesthesiol; 2014; 2014():250502. PubMed ID: 24971182
[TBL] [Abstract][Full Text] [Related]
36. Rare postoperative delayed malignant hyperthermia after off-pump coronary bypass surgery and brief review of literature.
Raut MS; Kar S; Maheshwari A; Shivnani G; Kumar A; Daniel E; Joshi S; Motihar A; Gupta P
Ann Card Anaesth; 2016; 19(2):357-62. PubMed ID: 27052086
[TBL] [Abstract][Full Text] [Related]
37. Complications associated with the administration of dantrolene 1987 to 2006: a report from the North American Malignant Hyperthermia Registry of the Malignant Hyperthermia Association of the United States.
Brandom BW; Larach MG; Chen MS; Young MC
Anesth Analg; 2011 May; 112(5):1115-23. PubMed ID: 21372281
[TBL] [Abstract][Full Text] [Related]
38. Safety of general anesthesia in patients previously tested negative for malignant hyperthermia susceptibility.
Allen GC; Rosenberg H; Fletcher JE
Anesthesiology; 1990 Apr; 72(4):619-22. PubMed ID: 2321777
[TBL] [Abstract][Full Text] [Related]
39. Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.
Larach MG; Klumpner TT; Brandom BW; Vaughn MT; Belani KG; Herlich A; Kim TW; Limoncelli J; Riazi S; Sivak EL; Capacchione J; Mashman D; Kheterpal S; Kooij F; Wilczak J; Soto R; Berris J; Price Z; Lins S; Coles P; Harris JM; Cummings KC; Berman MF; Nanamori M; Adelman BT; Wedeven C; LaGorio J; McCormick PJ; Tom S; Aziz MF; Coffman T; Ellis TA; Molina S; Peterson W; Mackey SC; van Klei WA; Ginde AA; Biggs DA; Neuman MD; Craft RM; Pace NL; Paganelli WC; Durieux ME; Nair BJ; Wanderer JP; Miller SA; Helsten DL; Turnbull ZA; Schonberger RB;
Anesthesiology; 2019 Jan; 130(1):41-54. PubMed ID: 30550426
[TBL] [Abstract][Full Text] [Related]
40. [Fulminant malignant hyperthermia during the 6th general anesthesia using volatile anesthetics].
Striebel HW; Lechner J; Wiegand C; Hartung E
Anasthesiol Intensivmed Notfallmed Schmerzther; 1991 Dec; 26(8):475-80. PubMed ID: 1786310
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
